These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29206664)

  • 1. Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group.
    Kojima A; Shimada M; Mikami Y; Nagao S; Takeshima N; Sugiyama T; Teramoto N; Kiyokawa T; Kigawa J; Nishimura R;
    Int J Gynecol Cancer; 2018 Jan; 28(1):99-106. PubMed ID: 29206664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix.
    Shimada M; Nagao S; Fujiwara K; Takeshima N; Takizawa K; Shoji T; Sugiyama T; Yamaguchi S; Nishimura R; Kigawa J
    Int J Clin Oncol; 2016 Dec; 21(6):1128-1135. PubMed ID: 27380169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional study.
    Nishio S; Mikami Y; Tokunaga H; Yaegashi N; Satoh T; Saito M; Okamoto A; Kasamatsu T; Miyamoto T; Shiozawa T; Yoshioka Y; Mandai M; Kojima A; Takehara K; Kaneki E; Kobayashi H; Kaku T; Ushijima K; Kamura T
    Gynecol Oncol; 2019 Apr; 153(1):13-19. PubMed ID: 30709650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility Study of Adjuvant Chemotherapy Using Taxane Plus Carboplatin for High-Risk Patients With Uterine Cervical Non-Squamous Cell Carcinoma After Radical Hysterectomy.
    Sato S; Shimada M; Ohta T; Kojimahara T; Tokunaga H; Takano T; Yamaguchi S; Tanabe H; Nishio S; Kigawa J
    Int J Gynecol Cancer; 2016 Mar; 26(3):561-7. PubMed ID: 26825829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional Direct Smear Yields Diagnostic Indicators of Gastric-Type Mucinous Carcinoma Compared with Cytomorphological Features Identified by Liquid-Based Cervical Cytology.
    Ryu A; Nagata S; Kubo C; Ueda Y; Tanada S; Idota A; Kamiura S; Honma K; Yamasaki T
    Acta Cytol; 2021; 65(2):150-157. PubMed ID: 33176300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
    Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer. A pilot study.
    Nagao S; Fujiwara K; Oda T; Ishikawa H; Koike H; Tanaka H; Kohno I
    Gynecol Oncol; 2005 Mar; 96(3):805-9. PubMed ID: 15721429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of postoperative adjuvant therapy in 102 patients with gastric-type mucinous carcinoma of the uterine cervix: A multi-institutional study.
    Nishio S; Matsuo K; Nasu H; Murotani K; Mikami Y; Yaegashi N; Satoh T; Okamoto A; Ishikawa M; Miyamoto T; Mandai M; Takehara K; Yahata H; Takekuma M; Ushijima K
    Eur J Surg Oncol; 2022 Sep; 48(9):2039-2044. PubMed ID: 35354541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of combination chemotherapy with docetaxel and carboplatin for locally advanced or recurrent cervical cancer.
    Takekida S; Fujiwara K; Nagao S; Yamaguchi S; Yoshida N; Kitada F; Kigawa J; Terakawa N; Nishimura R
    Int J Gynecol Cancer; 2010 Dec; 20(9):1563-8. PubMed ID: 21370599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
    Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
    Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of combination chemotherapy using docetaxel and irinotecan for TC-refractory or TC-resistant ovarian carcinomas (GOGO-OV2 study) and for primary clear or mucinous ovarian carcinomas (GOGO-OV3 Study).
    Ueda Y; Miyatake T; Nagamatsu M; Yamasaki M; Nishio Y; Yoshino K; Fujita M; Tsutsui T; Enomoto T; Kimura T
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):259-63. PubMed ID: 23880598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytologic features of gastric-type adenocarcinoma of the uterine cervix.
    Kawakami F; Mikami Y; Sudo T; Fujiwara K; Hirose T; Itoh T
    Diagn Cytopathol; 2015 Oct; 43(10):791-6. PubMed ID: 26173165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial on cisplatin-adriamycin-paclitaxel combination as neoadjuvant chemotherapy for locally advanced cervical adenocarcinoma.
    Lorusso D; Ramondino S; Mancini M; Zanaboni F; Ditto A; Raspagliesi F
    Int J Gynecol Cancer; 2014 May; 24(4):729-34. PubMed ID: 24662130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine Cervix.
    Chung T; DO SI; Na K; Kim G; Jeong YI; Kim YW; Kim HS
    Anticancer Res; 2018 Jun; 38(6):3551-3558. PubMed ID: 29848709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin.
    Takekuma M; Hirashima Y; Takahashi N; Yamamichi G; Furukawa N; Yamada Y; Takakuwa R; Ito I
    Anticancer Drugs; 2006 Jul; 17(6):715-8. PubMed ID: 16917218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
    Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
    Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric-type Endocervical Adenocarcinoma: An Aggressive Tumor With Unusual Metastatic Patterns and Poor Prognosis.
    Karamurzin YS; Kiyokawa T; Parkash V; Jotwani AR; Patel P; Pike MC; Soslow RA; Park KJ
    Am J Surg Pathol; 2015 Nov; 39(11):1449-57. PubMed ID: 26457350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the clinicopathologic features of 88 cases with mucinous cervical adenocarcinoma].
    Zeng SY; Zhong ML; Liang MR; Li L; Jiang W; Yu XH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):602-6. PubMed ID: 24199926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.
    McCaffrey R; Bahtiyar M; Kohorn EI; Chambers JT; Schwartz PE; Chambers SK
    Int J Gynecol Cancer; 2011 Apr; 21(3):535-44. PubMed ID: 21436702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.